Finanical Statements
Glaxo Smith Kline (BIOC.CA) Reports 3 Months Standalone Results
Published at 17 May 2026 at 12:55Related stock: BIOC
AI Summary
AI-powered disclosure summary — Coming soon 🔜
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 31/03/2026
Net Profit : 41,775,942
F/S Standalone Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 43,559,059
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Standalone Financial Statements in Arabic (6,060 KB)
The Standalone Financial Statements in English (6,652 KB)
ISIN Code : EGS38171C012
Currency : EGP
F/S Standalone Period : From 01/01/2026 To 31/03/2026
Net Profit : 41,775,942
F/S Standalone Period : From 01/01/2025 To 31/03/2025
Net Comparative Profit : 43,559,059
Audit Status : Reviewed
Source : Glaxo Smith Kline
The Standalone Financial Statements in Arabic (6,060 KB)
The Standalone Financial Statements in English (6,652 KB)